	贸易债权人		日
Acadia Pharmaceuticals	USD 12.25M	1.34M	2026-03
Adma Biologics	USD 20.52M	2M	2026-03
ALKERMES	USD 102.36M	5.59M	2026-03
Alterity Therapeutics Limited	AUD 1.07M	203.72K	2025-12
AstraZeneca	USD 22.51B	2.78B	2026-03
BioCryst Pharmaceuticals	USD 10.96M	4.87M	2026-03
Bristol-Myers Squibb	USD 4.23B	659M	2026-03
Cipla	INR 32.3B	1.95B	2026-03
Clal Biotechnology	ILS 21.05M	1.62M	2021-12
Compugen	USD 2.35M	6.77M	2025-12
CSL	USD 3.17B	290M	2025-12
Eli Lilly	USD 5.03B	350M	2026-03
Esperion Therapeutics	USD 68.41M	3.34M	2026-03
GlaxoSmithKline	GBP 14.34B	1.05B	2026-03
Grifols	EUR 987.75M	47.87M	2025-12
Halozyme Therapeutics	USD 14.1M	6.8M	2026-03
Ionis Pharmaceuticals	USD 26.03M	2.05M	2026-03
J&J	USD 10.46B	1.53B	2026-03
Merck	USD 3.86B	541M	2026-03
Minerva Neurosciences	USD 640K	305K	2025-12
Neurocrine Biosciences	USD 691.3M	145.8M	2026-03
Novartis	USD 4.32B	134M	2026-03
Novavax	USD 16.1M	8.48M	2026-03
Pfizer	USD 4.51B	734M	2026-03
Roche Holding	CHF 5.78B	1.27B	2025-12
Sanofi	EUR 22.71B	219M	2026-03
Takeda	JPY 491.34B	23.75B	2026-03
Vanda Pharmaceuticals	USD 39.09M	33.28M	2024-12